Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study
- PMID: 34355281
- DOI: 10.1007/s10120-021-01222-4
Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study
Erratum in
-
Correction to: Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study.Gastric Cancer. 2022 Jan;25(1):42-43. doi: 10.1007/s10120-021-01240-2. Gastric Cancer. 2022. PMID: 34463823 No abstract available.
-
Correction to: Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study.Gastric Cancer. 2022 Mar;25(2):479. doi: 10.1007/s10120-022-01281-1. Gastric Cancer. 2022. PMID: 35147787 No abstract available.
Abstract
Background: We aimed to investigate the association between the triglyceride-glucose (TyG) index and gastric carcinogenesis, including precancerous conditions such as dysplasia, atrophic gastritis, and intestinal metaplasia.
Methods: Patients who received an upper endoscopic assessment at a medical center were included. The enrolled patients were divided into four categories according to their TyG index quartile (Q). To evaluate the relationship between increase of TyG index and gastric cancer, we analyzed the patients who received a health checkup twice. Moreover, receiver-operating characteristic curve analysis was used to establish cut-off value of the TyG index for gastric cancer.
Results: Of 127,564 enrolled patients, 43,525 (34.1%) and 186 (0.1%) were diagnosed with precancerous conditions and gastric cancer, respectively. The odds ratios (ORs) of precancerous conditions given TyG index progressively increased across quartiles: using Q1 as the reference: Q2 (OR = 1.403, P < 0.001), Q3 (OR = 1.646, P < 0.001), and Q4 (OR = 1.656, P < 0.001). The ORs of gastric cancer also increased according to the quartiles: Q2 (OR = 1.619, P = 0.045), Q3 (OR = 2.180, P = 0.004), and Q4 (OR = 2.363, P = 0.001). Moreover, the increase in TyG index between baseline and follow-up tests was more significant in gastric cancer group than in control group (P = 0.001). The optimal cut-off value for predicting gastric cancer was 9.73.
Conclusions: The TyG index may be a novel predictive biomarker for gastric carcinogenesis. Notably, increase in the TyG index is significantly associated with gastric cancer.
Keywords: Gastric cancer; Gastric carcinogenesis; Insulin resistance; Metabolic syndrome; Triglyceride-glucose index.
© 2021. The International Gastric Cancer Association and The Japanese Gastric Cancer Association.
Comment in
-
Comment on: "Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study. Gastric cancer, 2021 Aug 5" by Kim et al.Gastric Cancer. 2021 Nov;24(6):1370-1371. doi: 10.1007/s10120-021-01232-2. Epub 2021 Aug 23. Gastric Cancer. 2021. PMID: 34426941 No abstract available.
-
Reply to the letter by Junjie Jiang et al. regarding our manuscript "Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study".Gastric Cancer. 2021 Nov;24(6):1372-1373. doi: 10.1007/s10120-021-01245-x. Epub 2021 Sep 4. Gastric Cancer. 2021. PMID: 34480658 No abstract available.
Similar articles
-
Triglyceride-glucose index is associated with gastroesophageal reflux disease and erosive reflux disease: a health checkup cohort study.Sci Rep. 2022 Dec 5;12(1):20959. doi: 10.1038/s41598-022-25536-0. Sci Rep. 2022. PMID: 36470993 Free PMC article.
-
Association between triglyceride glucose index and subclinical left ventricular systolic dysfunction in patients with type 2 diabetes.Lipids Health Dis. 2023 Mar 8;22(1):35. doi: 10.1186/s12944-023-01796-1. Lipids Health Dis. 2023. PMID: 36890516 Free PMC article.
-
Predictive value of triglyceride/glucose index (TyG) in predicting breast cancer in patients with breast mass.Eur Rev Med Pharmacol Sci. 2022 Jul;26(13):4671-4676. doi: 10.26355/eurrev_202207_29191. Eur Rev Med Pharmacol Sci. 2022. PMID: 35856358
-
The association between triglyceride-glucose index and major adverse cardiovascular events in patients with acute coronary syndrome - dose-response meta-analysis.Nutr Metab Cardiovasc Dis. 2021 Oct 28;31(11):3024-3030. doi: 10.1016/j.numecd.2021.08.026. Epub 2021 Aug 12. Nutr Metab Cardiovasc Dis. 2021. PMID: 34625361
-
Environmental factors associated with gastric carcinogenesis.Curr Opin Gastroenterol. 2022 Mar 1;38(2):156-161. doi: 10.1097/MOG.0000000000000812. Curr Opin Gastroenterol. 2022. PMID: 35098937 Review.
Cited by
-
Impact of triglyceride-glucose index on the long-term prognosis of advanced gastric cancer patients receiving immunotherapy combined with chemotherapy.World J Gastroenterol. 2025 Feb 7;31(5):102249. doi: 10.3748/wjg.v31.i5.102249. World J Gastroenterol. 2025. PMID: 39926212 Free PMC article.
-
Association between surrogate markers of insulin resistance and gastric cancer risk in South Korea: A nationwide population-based study.Medicine (Baltimore). 2025 Aug 1;104(31):e42324. doi: 10.1097/MD.0000000000042324. Medicine (Baltimore). 2025. PMID: 40760586 Free PMC article.
-
Association between four insulin resistance surrogates and the risk of esophageal cancer: a prospective cohort study using the UK Biobank.J Cancer Res Clin Oncol. 2024 Aug 24;150(8):399. doi: 10.1007/s00432-024-05919-8. J Cancer Res Clin Oncol. 2024. PMID: 39180548 Free PMC article.
-
Triglyceride-glucose index as a marker of adverse cardiovascular prognosis in patients with coronary heart disease and hypertension.Cardiovasc Diabetol. 2023 Jun 9;22(1):133. doi: 10.1186/s12933-023-01866-9. Cardiovasc Diabetol. 2023. PMID: 37296406 Free PMC article.
-
Association between the triglyceride glucose index and short-term mortality in septic patients with or without obesity: a retrospective cohort study.Adipocyte. 2024 Dec;13(1):2379867. doi: 10.1080/21623945.2024.2379867. Epub 2024 Jul 16. Adipocyte. 2024. PMID: 39011965 Free PMC article.
References
-
- Collaborators GBDSC. The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):42–54.
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. - DOI
-
- Rugge M. Gastric cancer risk: between genetics and lifestyle. Lancet Oncol. 2020;21(10):1258–60. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical